Xylem (XYL) Asset Writedowns and Impairment (2011 - 2025)

Xylem's Asset Writedowns and Impairment history runs 10 years deep, the most recent figure standing at $4.0 million for Q2 2025.

• In Q2 2025, Asset Writedowns and Impairment fell 69.23% year-over-year to $4.0 million; the TTM figure through Mar 2026 stood at $4.0 million (down 82.61% YoY), while the FY2025 annual figure was $8.0 million, up 14.29% from the prior year.
• Asset Writedowns and Impairment for Q2 2025 stood at $4.0 million, roughly flat from $4.0 million in the prior quarter.
• The five-year high for Asset Writedowns and Impairment was $14.0 million in Q3 2022, with the low at $1.0 million in Q1 2021.
• The 5-year median for Asset Writedowns and Impairment is $1.5 million (2021), against an average of $4.1 million.
• The sharpest annual moves came in 2023 and 2024: Asset Writedowns and Impairment tumbled 92.86% in 2023, then surged 500.0% in 2024.
• Xylem's Asset Writedowns and Impairment stood at $1.0 million in 2021, then changed by 0.0% to $1.0 million in 2022, then changed by 0.0% to $1.0 million in 2023, then soared by 500.0% to $6.0 million in 2024, then plunged by 33.33% to $4.0 million in 2025.
• Business Quant data shows XYL's Asset Writedowns and Impairment at $4.0 million in Q2 2025, $4.0 million in Q1 2025, and $6.0 million in Q4 2024.